High-dose cytosine arabinoside in the consolidation therapy of acute nonlymphocytic leukemia in remission. 1987

F Takaku, and A Urabe, and H Mizoguchi, and S Hoshino, and K Toyama, and K Tanaka, and T Nomura, and K Dan, and S Fujioka, and T Saito

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D008297 Male Males
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D008775 Methylprednisolone A PREDNISOLONE derivative with similar anti-inflammatory action. 6-Methylprednisolone,Medrol,Metipred,Urbason,6 Methylprednisolone
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003561 Cytarabine A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472) Ara-C,Arabinofuranosylcytosine,Arabinosylcytosine,Cytosine Arabinoside,Aracytidine,Aracytine,Cytarabine Hydrochloride,Cytonal,Cytosar,Cytosar-U,beta-Ara C,Ara C,Arabinoside, Cytosine,Cytosar U,beta Ara C
D003630 Daunorubicin A very toxic anthracycline aminoglycoside antineoplastic isolated from Streptomyces peucetius and others, used in treatment of LEUKEMIA and other NEOPLASMS. Daunomycin,Rubidomycin,Rubomycin,Cerubidine,Dauno-Rubidomycine,Daunoblastin,Daunoblastine,Daunorubicin Hydrochloride,NSC-82151,Dauno Rubidomycine,Hydrochloride, Daunorubicin,NSC 82151,NSC82151
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

F Takaku, and A Urabe, and H Mizoguchi, and S Hoshino, and K Toyama, and K Tanaka, and T Nomura, and K Dan, and S Fujioka, and T Saito
February 1991, International journal of hematology,
F Takaku, and A Urabe, and H Mizoguchi, and S Hoshino, and K Toyama, and K Tanaka, and T Nomura, and K Dan, and S Fujioka, and T Saito
June 1987, Seminars in oncology,
F Takaku, and A Urabe, and H Mizoguchi, and S Hoshino, and K Toyama, and K Tanaka, and T Nomura, and K Dan, and S Fujioka, and T Saito
June 1985, Blood,
F Takaku, and A Urabe, and H Mizoguchi, and S Hoshino, and K Toyama, and K Tanaka, and T Nomura, and K Dan, and S Fujioka, and T Saito
January 1984, American journal of hematology,
F Takaku, and A Urabe, and H Mizoguchi, and S Hoshino, and K Toyama, and K Tanaka, and T Nomura, and K Dan, and S Fujioka, and T Saito
January 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
F Takaku, and A Urabe, and H Mizoguchi, and S Hoshino, and K Toyama, and K Tanaka, and T Nomura, and K Dan, and S Fujioka, and T Saito
January 2014, Medicinski pregled,
F Takaku, and A Urabe, and H Mizoguchi, and S Hoshino, and K Toyama, and K Tanaka, and T Nomura, and K Dan, and S Fujioka, and T Saito
April 2012, Mymensingh medical journal : MMJ,
F Takaku, and A Urabe, and H Mizoguchi, and S Hoshino, and K Toyama, and K Tanaka, and T Nomura, and K Dan, and S Fujioka, and T Saito
January 1983, Blood,
F Takaku, and A Urabe, and H Mizoguchi, and S Hoshino, and K Toyama, and K Tanaka, and T Nomura, and K Dan, and S Fujioka, and T Saito
June 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
F Takaku, and A Urabe, and H Mizoguchi, and S Hoshino, and K Toyama, and K Tanaka, and T Nomura, and K Dan, and S Fujioka, and T Saito
January 1988, Acta haematologica,
Copied contents to your clipboard!